Evaluation for efficacy and safety of Angiotensin Converting Enzyme Inhibitor in treatment of proteinuria in cyanotic congenital heart diseases
Phase 2
- Conditions
- oxygen saturationurine proteinserum creatinineenalapril,proteinuria,microalbuminuria,cyanotic heart diseases
- Registration Number
- TCTR20180208003
- Lead Sponsor
- Faculty of Medicine, Chiang Mai University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending (Not yet recruiting)
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
cyanotic congenital heart diseases with microalbuminuria
Exclusion Criteria
Patients that have contraindicated for enalapril
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method proteinuria 0, 1, 3 month urine protein analysis
- Secondary Outcome Measures
Name Time Method renal function 0, 1, 3 month serum Creatinine